{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:51:33Z","timestamp":1794671493302,"version":"4.9.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute on Aging, Intramural Research Program","id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institute of Neurological Disorders and Stroke, Intramural Research Program","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Uniformed Services University, Intramural Research Program","id":[{"id":"https:\/\/ror.org\/04r3kq386","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institute of Allergy and Infectious Diseases, Intramural Research Program","id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["1ZIAAG000933"],"award-info":[{"award-number":["1ZIAAG000933"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007188","name":"United States Department of Defense | Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Identifying a reliable biomarker for amyotrophic lateral sclerosis (ALS) is crucial for clinical practice. Here, in this cross-sectional study, we used the Olink Explore 3072 platform to investigate plasma proteomics as a biomarker tool for this neurodegenerative condition. Thirty-three proteins were differentially abundant in the plasma of patients with ALS (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009183) versus controls (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009309). We replicated our findings in an independent cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200948 patients with ALS and\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200975 controls). We then applied machine learning to create a model that diagnosed ALS with high accuracy (area under the curve,\u200998.3%). By analyzing plasma samples from individuals before ALS symptoms emerged, we estimated the age of clinical onset and showed that the disease process\u2014impacting skeletal muscle, nerves and energy metabolism\u2014occurs years before symptoms appear. Our research suggests that plasma proteins can be a biomarker for this fatal disease and offers molecular insights into its prodromal phase.\n                  <\/jats:p>","DOI":"10.1038\/s41591-025-03890-6","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T09:04:22Z","timestamp":1755594262000},"page":"3440-3450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4709-7423","authenticated-orcid":false,"given":"Ruth","family":"Chia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6812-0127","authenticated-orcid":false,"given":"Ruin","family":"Moaddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Y.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Memoona","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ruffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Landeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-8680","authenticated-orcid":false,"given":"Paolo","family":"Reho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Vasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5122-7243","authenticated-orcid":false,"given":"Andrea","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Moglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5876-4079","authenticated-orcid":false,"given":"Antonio","family":"Canosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Manera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-928X","authenticated-orcid":false,"given":"Allison","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Saez-Atienzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6714-6897","authenticated-orcid":false,"given":"Maurizio","family":"Grassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1097-1279","authenticated-orcid":false,"given":"Federico","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Arvind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Comertpay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-0658","authenticated-orcid":false,"given":"J. Raphael","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The American Genome Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6459-0893","authenticated-orcid":false,"given":"Ted M.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5140-3967","authenticated-orcid":false,"given":"Liana S.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6427-7485","authenticated-orcid":false,"given":"Alexander Y.","family":"Pantelyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek P.","family":"Narendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-6766","authenticated-orcid":false,"given":"Debra J.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5989-9853","authenticated-orcid":false,"given":"Keenan A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-9430","authenticated-orcid":false,"given":"Bibiana","family":"Bielekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-0053","authenticated-orcid":false,"given":"Josephine M.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5793-8989","authenticated-orcid":false,"given":"Juli\u00e1n","family":"Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6273-1613","authenticated-orcid":false,"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2025-8239","authenticated-orcid":false,"given":"Clifton L.","family":"Dalgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6623-0429","authenticated-orcid":false,"given":"Sonja W.","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-5341","authenticated-orcid":false,"given":"Adriano","family":"Chi\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0527-2446","authenticated-orcid":false,"given":"Bryan J.","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"3890_CR1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Amyotrophic lateral sclerosis. Lancet 400, 1363\u20131380 (2022).","journal-title":"Lancet"},{"key":"3890_CR2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12408","volume":"7","author":"KC Arthur","year":"2016","unstructured":"Arthur, K. C. et al. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat. Commun. 7, 12408 (2016).","journal-title":"Nat. Commun."},{"key":"3890_CR3","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s13311-022-01271-2","volume":"19","author":"CN Fournier","year":"2022","unstructured":"Fournier, C. N. Considerations for amyotrophic lateral sclerosis (ALS) clinical trial design. Neurotherapeutics 19, 1180\u20131192 (2022).","journal-title":"Neurotherapeutics"},{"key":"3890_CR4","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori, P. & Van Damme, P. Amyotrophic lateral sclerosis: a clinical review. Eur. J. Neurol. 27, 1918\u20131929 (2020).","journal-title":"Eur. J. Neurol."},{"key":"3890_CR5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","volume":"12","author":"MR Turner","year":"2013","unstructured":"Turner, M. R. et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 12, 310\u2013322 (2013).","journal-title":"Lancet Neurol."},{"key":"3890_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","volume":"41","author":"A Chi\u00f2","year":"2013","unstructured":"Chi\u00f2, A. et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41, 118\u2013130 (2013).","journal-title":"Neuroepidemiology"},{"key":"3890_CR7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","volume":"82","author":"A Chi\u00f2","year":"2011","unstructured":"Chi\u00f2, A. et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J. Neurol. Neurosurg. Psychiatry 82, 740\u2013746 (2011).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"3890_CR8","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/WNL.0b013e318232ab9b","volume":"77","author":"A Chi\u00f2","year":"2011","unstructured":"Chi\u00f2, A. et al. ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology 77, 1432\u20131437 (2011).","journal-title":"Neurology"},{"key":"3890_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.56.2.239","volume":"56","author":"Piemonte and Valle d\u2019Aosta Register for Amyotrophic Lateral Sclerosis (PARALS).","year":"2001","unstructured":"Piemonte and Valle d\u2019Aosta Register for Amyotrophic Lateral Sclerosis (PARALS).Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 56, 239\u2013244 (2001).","journal-title":"Neurology"},{"key":"3890_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks, B. R., Miller, R. G., Swash, M. & Munsat, T. L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 1, 293\u2013299 (2000).","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"3890_CR11","doi-asserted-by":"crossref","first-page":"eabm5164","DOI":"10.1126\/sciadv.abm5164","volume":"8","author":"DH Katz","year":"2022","unstructured":"Katz, D. H. et al. Proteomic profiling platforms head to head: leveraging genetics and clinical traits to compare aptamer- and antibody-based methods. Sci. Adv. 8, eabm5164 (2022).","journal-title":"Sci. Adv."},{"key":"3890_CR12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani, L. et al. Neurofilament light chain as a biomarker in neurological disorders. J. Neurol. Neurosurg. Psychiatry 90, 870\u2013881 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"3890_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0006-8993(03)02989-5","volume":"982","author":"MF Azari","year":"2003","unstructured":"Azari, M. F. et al. Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1G93A G1H mouse model of familial amyotrophic lateral sclerosis. Brain Res. 982, 92\u201397 (2003).","journal-title":"Brain Res."},{"key":"3890_CR14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","volume":"1762","author":"L Van Den Bosch","year":"2006","unstructured":"Van Den Bosch, L., Van Damme, P., Bogaert, E. & Robberecht, W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762, 1068\u20131082 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"3890_CR15","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1093\/brain\/awad202","volume":"146","author":"JM Shefner","year":"2023","unstructured":"Shefner, J. M. et al. Skeletal muscle in amyotrophic lateral sclerosis. Brain 146, 4425\u20134436 (2023).","journal-title":"Brain"},{"key":"3890_CR16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","volume":"135","author":"T Vandoorne","year":"2018","unstructured":"Vandoorne, T., De Bock, K. & Van Den Bosch, L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 135, 489\u2013509 (2018).","journal-title":"Acta Neuropathol."},{"key":"3890_CR17","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","volume":"53","author":"W van Rheenen","year":"2021","unstructured":"van Rheenen, W. et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 53, 1636\u20131648 (2021).","journal-title":"Nat. Genet."},{"key":"3890_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"3890_CR19","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/S2589-7500(21)00274-0","volume":"4","author":"F Faghri","year":"2022","unstructured":"Faghri, F. et al. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study. Lancet Digit. Health 4, e359\u2013e369 (2022).","journal-title":"Lancet Digit. Health"},{"key":"3890_CR20","unstructured":"Lundberg, S. M. & Lee, S. A unified approach to interpreting model predictions. In Proc. 31st International Conference on Neural Information Processing Systems 4768\u20134777 (Curran Associates, 2017)."},{"key":"3890_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","volume":"19","author":"KE Irwin","year":"2024","unstructured":"Irwin, K. E., Sheth, U., Wong, P. C. & Gendron, T. F. Fluid biomarkers for amyotrophic lateral sclerosis: a review. Mol. Neurodegener. 19, 9 (2024).","journal-title":"Mol. Neurodegener."},{"key":"3890_CR22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman, S. A. et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 21, 480\u2013493 (2022).","journal-title":"Lancet Neurol."},{"key":"3890_CR23","doi-asserted-by":"crossref","first-page":"eabd9036","DOI":"10.1126\/sciadv.abd9036","volume":"7","author":"S Saez-Atienzar","year":"2021","unstructured":"Saez-Atienzar, S. et al. Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types. Sci. Adv. 7, eabd9036 (2021).","journal-title":"Sci. Adv."},{"key":"3890_CR24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jamaneurol.2017.1387","volume":"74","author":"A Chi\u00f2","year":"2017","unstructured":"Chi\u00f2, A. et al. Secular trends of amyotrophic lateral sclerosis: the Piemonte and Valle d\u2019Aosta Register. JAMA Neurol. 74, 1097\u20131104 (2017).","journal-title":"JAMA Neurol."},{"key":"3890_CR25","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","volume":"67","author":"LE Rosengren","year":"1996","unstructured":"Rosengren, L. E., Karlsson, J. E., Karlsson, J. O., Persson, L. I. & Wikkelso, C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J. Neurochem. 67, 2013\u20132018 (1996).","journal-title":"J. Neurochem."},{"key":"3890_CR26","doi-asserted-by":"crossref","first-page":"fcad163","DOI":"10.1093\/braincomms\/fcad163","volume":"5","author":"JC Davies","year":"2023","unstructured":"Davies, J. C. et al. Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis. Brain Commun. 5, fcad163 (2023).","journal-title":"Brain Commun."},{"key":"3890_CR27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.neuron.2014.10.031","volume":"84","author":"AS Chen-Plotkin","year":"2014","unstructured":"Chen-Plotkin, A. S. Unbiased approaches to biomarker discovery in neurodegenerative diseases. Neuron 84, 594\u2013607 (2014).","journal-title":"Neuron"},{"key":"3890_CR28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/clinchem\/hvac186","volume":"69","author":"MR Rooney","year":"2023","unstructured":"Rooney, M. R. et al. Comparison of proteomic measurements across platforms in the Atherosclerosis Risk in Communities (ARIC) study. Clin. Chem. 69, 68\u201379 (2023).","journal-title":"Clin. Chem."},{"key":"3890_CR29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1021\/acs.jproteome.0c00641","volume":"20","author":"A Petrera","year":"2021","unstructured":"Petrera, A. et al. Multiplatform approach for plasma proteomics: complementarity of Olink proximity extension assay technology to mass spectrometry-based protein profiling. J. Proteome Res. 20, 751\u2013762 (2021).","journal-title":"J. Proteome Res."},{"key":"3890_CR30","volume":"131","author":"F Xu","year":"2024","unstructured":"Xu, F. et al. Olink proteomics analysis uncovers inflammatory proteins in patients with different states of bipolar disorder. Int. Immunopharmacol. 131, 111816 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"3890_CR31","volume":"14","author":"T Wang","year":"2023","unstructured":"Wang, T. et al. Olink proteomics analysis uncovers the landscape of inflammation-related proteins in patients with acute compartment syndrome. Front. Immunol. 14, 1293826 (2023).","journal-title":"Front. Immunol."},{"key":"3890_CR32","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1021\/acs.jproteome.4c00522","volume":"23","author":"S Xu","year":"2024","unstructured":"Xu, S. et al. Plasma Olink proteomics reveals novel biomarkers for prediction and diagnosis in dilated cardiomyopathy with heart failure. J. Proteome Res. 23, 4139\u20134150 (2024).","journal-title":"J. Proteome Res."},{"key":"3890_CR33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn, G. H. et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622, 348\u2013358 (2023).","journal-title":"Nature"},{"key":"3890_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nmeth1020","volume":"4","author":"S Fredriksson","year":"2007","unstructured":"Fredriksson, S. et al. Multiplexed protein detection by proximity ligation for cancer biomarker validation. Nat. Methods 4, 327\u2013329 (2007).","journal-title":"Nat. Methods"},{"key":"3890_CR35","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41374-022-00830-7","volume":"102","author":"M Cui","year":"2022","unstructured":"Cui, M., Cheng, C. & Zhang, L. High-throughput proteomics: a methodological mini-review. Lab. Invest. 102, 1170\u20131181 (2022).","journal-title":"Lab. Invest."},{"key":"3890_CR36","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-60761-685-6","volume-title":"The Handbook of Biomarkers","author":"KK Jain","year":"2010","unstructured":"Jain, K. K. The Handbook of Biomarkers (Humana Press, 2010)."},{"key":"3890_CR37","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942\u2013955 (2011).","journal-title":"Lancet"},{"key":"3890_CR38","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1200\/JCO.2009.22.3701","volume":"27","author":"SJ Mandrekar","year":"2009","unstructured":"Mandrekar, S. J. & Sargent, D. J. Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges. J. Clin. Oncol. 27, 4027\u20134034 (2009).","journal-title":"J. Clin. Oncol."},{"key":"3890_CR39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow, K., Hampel, H., Weiner, M. & Zetterberg, H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat. Rev. Neurol. 6, 131\u2013144 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"3890_CR40","doi-asserted-by":"crossref","first-page":"fcab086","DOI":"10.1093\/braincomms\/fcab086","volume":"3","author":"A Lleo","year":"2021","unstructured":"Lleo, A. Biomarkers in neurological disorders: a fast-growing market. Brain Commun. 3, fcab086 (2021).","journal-title":"Brain Commun."},{"key":"3890_CR41","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","volume":"84","author":"CH Lu","year":"2015","unstructured":"Lu, C. H. et al. Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology 84, 2247\u20132257 (2015).","journal-title":"Neurology"},{"key":"3890_CR42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"3890_CR43","doi-asserted-by":"crossref","first-page":"e1466","DOI":"10.1212\/WNL.0000000000012632","volume":"97","author":"K Bjornevik","year":"2021","unstructured":"Bjornevik, K. et al. Prediagnostic neurofilament light chain levels in amyotrophic lateral sclerosis. Neurology 97, e1466\u2013e1474 (2021).","journal-title":"Neurology"},{"key":"3890_CR44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","volume":"2","author":"PE Geyer","year":"2016","unstructured":"Geyer, P. E. et al. Plasma proteome profiling to assess human health and disease. Cell Syst. 2, 185\u2013195 (2016).","journal-title":"Cell Syst."},{"key":"3890_CR45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson, N. L. & Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteom. 1, 845\u2013867 (2002).","journal-title":"Mol. Cell Proteom."},{"key":"3890_CR46","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","volume":"30","author":"KE Irwin","year":"2024","unstructured":"Irwin, K. E. et al. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS\u2013FTD. Nat. Med. 30, 382\u2013393 (2024).","journal-title":"Nat. Med."},{"key":"3890_CR47","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/acn3.51871","volume":"10","author":"M Portley","year":"2023","unstructured":"Portley, M. et al. Cognitive determinants of decisional capacity in neurodegenerative disorders. Ann. Clin. Transl. Neurol. 10, 1816\u20131823 (2023).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"3890_CR48","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/gerona\/63.12.1416","volume":"63","author":"L Ferrucci","year":"2008","unstructured":"Ferrucci, L. The Baltimore Longitudinal Study of Aging (BLSA): a 50-year-long journey and plans for the future. J. Gerontol. A Biol. Sci. Med. Sci. 63, 1416\u20131419 (2008).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"3890_CR49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496\u2013503 (2013).","journal-title":"Neurology"},{"key":"3890_CR50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"3890_CR51","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre, M. et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov. Disord. 22, 1689\u20131707 (2007).","journal-title":"Mov. Disord."},{"key":"3890_CR52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman, S. et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71, 670\u2013676 (2008).","journal-title":"Neurology"},{"key":"3890_CR53","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"3890_CR54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger, G. U. et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov. Disord. 32, 853\u2013864 (2017).","journal-title":"Mov. Disord."},{"key":"3890_CR55","doi-asserted-by":"crossref","first-page":"e0172639","DOI":"10.1371\/journal.pone.0172639","volume":"12","author":"S Horrocks","year":"2017","unstructured":"Horrocks, S. et al. Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: a systematic review. PLoS ONE 12, e0172639 (2017).","journal-title":"PLoS ONE"},{"key":"3890_CR56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuron.2020.11.005","volume":"109","author":"R Dewan","year":"2021","unstructured":"Dewan, R. et al. Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis. Neuron 109, 448\u2013460 (2021).","journal-title":"Neuron"},{"key":"3890_CR57","doi-asserted-by":"crossref","first-page":"e1008432","DOI":"10.1371\/journal.pgen.1008432","volume":"15","author":"A Diaz-Papkovich","year":"2019","unstructured":"Diaz-Papkovich, A., Anderson-Trocme, L., Ben-Eghan, C. & Gravel, S. UMAP reveals cryptic population structure and phenotype heterogeneity in large genomic cohorts. PLoS Genet. 15, e1008432 (2019).","journal-title":"PLoS Genet."},{"key":"3890_CR58","doi-asserted-by":"crossref","first-page":"106373","DOI":"10.1016\/j.nbd.2023.106373","volume":"190","author":"J Timsina","year":"2024","unstructured":"Timsina, J. et al. Harmonization of CSF and imaging biomarkers in Alzheimer\u2019s disease: need and practical applications for genetics studies and preclinical classification. Neurobiol. Dis. 190, 106373 (2024).","journal-title":"Neurobiol. Dis."},{"key":"3890_CR59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11613\/BM.2015.015","volume":"25","author":"D Giavarina","year":"2015","unstructured":"Giavarina, D. Understanding Bland Altman analysis. Biochem. Med. 25, 141\u2013151 (2015).","journal-title":"Biochem. Med."},{"key":"3890_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22116-0","volume":"12","author":"J Candia","year":"2022","unstructured":"Candia, J., Daya, G. N., Tanaka, T., Ferrucci, L. & Walker, K. A. Assessment of variability in the plasma 7k SomaScan proteomics assay. Sci. Rep. 12, 17147 (2022).","journal-title":"Sci. Rep."},{"key":"3890_CR61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"3890_CR62","doi-asserted-by":"crossref","first-page":"D355","DOI":"10.1093\/nar\/gkp896","volume":"38","author":"M Kanehisa","year":"2010","unstructured":"Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M. & Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355\u2013D360 (2010).","journal-title":"Nucleic Acids Res."},{"key":"3890_CR63","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013D678 (2024).","journal-title":"Nucleic Acids Res."},{"key":"3890_CR64","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 7, e34408 (2018).","journal-title":"eLife"},{"key":"3890_CR65","first-page":"1157","volume":"3","author":"I Guyon","year":"2003","unstructured":"Guyon, I. & Elisseeff, A. An introduction to variable and feature selection. J. Mach. Learn. Res. 3, 1157\u20131182 (2003).","journal-title":"J. Mach. Learn. Res."},{"key":"3890_CR66","doi-asserted-by":"publisher","unstructured":"Chia, R. et al. Plasma proteomics defines a diagnostic biomarker panel for ALS. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14213102 (2025).","DOI":"10.5281\/zenodo.14213102"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03890-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T14:04:44Z","timestamp":1760623484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03890-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3890"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03890-6","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.C., R.M., J.Y.K., L.F., C.L.D., S.W.S. and B.J.T. have a patent pending (US Patent application no. 63\/717,807) on the diagnostic testing for ALS based on the proteomic panel. B.J.T. holds patents on the clinical testing and therapeutic intervention for the hexanucleotide repeat expansion of\n                      C9orf72\n                      . B.J.T. and S.W.S. receive research support from Cerevel Therapeutics. S.W.S. serves on the scientific advisory committees of the Lewy Body Dementia Association, Mission MSA and the GBA1 Canada Initiative. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}